Evidence map›Paper›PMID 37465230›Full record

ArticleVascular health and risk management2023

Racial Differences and Contributory Cardiovascular and Non-Cardiovascular Risk Factors Towards Chronic Kidney Disease Progression.

Yuni Choi, David R Jacobs, Holly J Kramer, Gautam R Shroff, Alexander R Chang, Daniel A Duprez

Open access · goldAbstract read
In one paragraph

Article in Vascular health and risk management, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yuni ChoiDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
David R JacobsDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Holly J KramerDepartments of Public Health Sciences and Medicine, Loyola University Chicago, Maywood, IL, USA.
Gautam R ShroffDivision of Cardiology and Department of Medicine, Hennepin Healthcare, University of Minnesota Medical School, Minneapolis, MN, USA.
Alexander R ChangDepartments of Population of Health Sciences and Nephrology, Geisinger, Danville, PA, USA.
Daniel A DuprezCardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-0993-6839
University of Minnesota · USGeisinger Health System · USLoyola University Chicago · US

Funding

Role of the Notch Pathway in Kidney InjuryR01DK076077 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATALIN SUSZTAK · 2007 to 2026
$8.0M
APOL1 associated kidney diseaseR01DK105821 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SUSZTAK, KATALIN · 2016 to 2024
$4.6M
Epigenetic drivers and biomarkers of diabetic kidney diseaseDP3DK108220 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SUSZTAK, KATALIN · 2015 to 2015
$2.4M
Urinary KNOWledge study (U-KNOW)R01DK104842 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI KRAMER, HOLLY JOY · 2016 to 2018
$1.0M
Screening Strategies for Chronic Kidney Disease in US PopulationsF32DK122627 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI TUMMALAPALLI, SRI LEKHA · 2019 to 2021
$159k
Analysis of Coding Variants Associated with Age-Related PhenotypesF31AG044879 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RAFFIELD, LAURA M · 2013 to 2015
$86k
Pharmacogenomics of risk factors and therapies outcomes for kidney diseaseI01BX003360 · VA · VETERANS HEALTH ADMINISTRATION · PI HUNG, ADRIANA · 2017 to 2020
–
BLRD VA I01 BX003360NIDDK NIH HHS DP3 DK108220NIDDK NIH HHS L30 DK065708NIDDK NIH HHS R01 DK076077NIDDK NIH HHS R01 DK104842NIDDK NIH HHS R01 DK105821
6 · The paper itself

Abstract

Background: The prevalence of advanced chronic kidney disease (CKD) is higher in Black than in White Americans. We evaluated CKD progression in Black and White participants and the contribution of biological risk factors. We included the study of lung function (measured by forced vital capacity [FVC]), which is part of the emerging notion of interorgan cross-talk with the kidneys to racial differences in CKD progression. Methods: This longitudinal study included 2175 Black and 2207 White adult Coronary Artery Risk Development in Young Adults (CARDIA) participants. Estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR) were measured at study year 10 (age 27-41y) and every five years for 20 years. The outcome was CKD progression through no CKD, low, moderate, high, or very high-risk categories based on eGFR and UACR in combination. The association between race and CKD progression as well as the contribution of risk factors to racial differences were assessed in multivariable-adjusted Cox models. Results: Black participants had higher CKD transition probabilities than White participants and more prevalent risk factors during the 20-year period studied. Hazard ratios for CKD transition for Black (vs White participants) were 1.38 from No CKD into ≥ low risk, 2.25 from ≤ low risk into ≥ moderate risk, and 4.49 from ≤ moderate risk into ≥ high risk. Racial differences in CKD progression from No CKD into ≥ low risk were primarily explained by FVC (54.8%), hypertension (30.9%), and obesity (20.8%). In contrast, racial differences were less explained in more severe transitions. Conclusion: Black participants had a higher risk of CKD progression, and this discrepancy may be partly explained by FVC and conventional risk factors.

Indexed as

Renal Insufficiency, ChronicAdultDisease ProgressionGlomerular Filtration RateHumansLongitudinal StudiesLungRace FactorsRisk FactorsYoung AdultCKD progressionconventional risk factorslung functionracial disparitiesyoung adults

Identifiers

PMID37465230
PMCPMC10350429
OpenAlexW4384068746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.